This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review (Mevissen et al., 2025) as motivation, emphasizing reported tissue-selective findings and non-monotonic dose patterns. The post proposes a mechanistic framework (“S4–Mito–Spin”) and calls for research to map boundary conditions across tissues and exposure parameters to inform standards beyond SAR/thermal assumptions.

RF Safe argues that “no effect” findings in some RF exposure studies should be interpreted as meaningful negative controls rather than as evidence that RF has no biological effects. The post presents RF Safe’s “S4–Mito–Spin” framework, claiming certain skin cell types (fibroblasts and keratinocytes) are predicted to be relatively resistant to non-thermal RF effects, so null results in these cells can be consistent with the model. It cites in-vitro studies at 3.5 GHz (5G-modulated) reporting no changes in ROS measures, stress responses, or UV-B DNA repair kinetics under specified SAR conditions, and frames these nulls as boundary conditions rather than a general safety conclusion.

RF Safe presents itself as an RF exposure advocacy and education project promoting “RF exposure literacy,” safer-use habits, and updated safety frameworks beyond thermal-only assumptions. The post highlights RF Safe’s tools, including a SAR comparison database based on FCC SAR data, a public research viewer described as containing 4,000+ peer-reviewed studies, and its “TruthCase”/editorial standards. It argues that non-thermal biological interactions are reported in experimental literature and that compliance with current SAR limits does not necessarily reflect optimal real-world exposure outcomes.

This rat study examined 2.45 GHz WLAN-like EMF exposure (3 V/m; SAR 0.00208 W/kg) for 1 hour/day over 60 days and assessed testicular morphology and VEGF-related markers. The abstract reports increased VEGFA gene expression and protein levels in exposed animals, with no change in HIF1A expression. It also reports multiple histological changes interpreted as testicular damage in the exposed group.

RF Safe promotes an education-first, zero-paid-ad marketing approach for its EMF safety products, positioning itself against what it describes as a market full of overhyped or misleading “anti-radiation” gadgets. The article highlights RF Safe’s resources (e.g., a large study library and SAR tools) and argues its products (notably the QuantaCase) align with “physics” and avoid deceptive claims. It also repeats the founder’s personal story linking a family tragedy to prenatal EMF exposure and references various external claims (e.g., WHO animal findings, court criticism of FCC limits) without providing primary documentation in the text.

RF Safe recaps a Truth Expedition podcast episode featuring RF Safe founder John Coates discussing alleged biological risks from EMF exposure and arguing that current regulations lag behind modern science. The piece links EMFs to developmental and health concerns (including neural-tube defects and autism) via Coates’ proposed “S4–Mito–Spin” framework involving voltage-gated ion channels, mitochondrial signaling, and radical-pair/spin chemistry. It also promotes RF Safe’s research library, SAR comparison tools, and mitigation products as part of a risk-reduction approach.

RF Safe argues that animal evidence for RF-related carcinogenicity is now strong and should not be dismissed, citing the NTP (2018) and Ramazzini (2018) lifetime rodent studies as showing statistically significant increases in the same rare tumor types (heart schwannomas and brain gliomas). The post further claims that effects occurred at relatively low whole-body SAR levels and references additional mechanistic hypotheses (e.g., VGCC-related models and radical-pair/spin effects) and a reported human ultrasound observation of acute non-thermal changes. These points are presented as supporting a shift away from a “thermal-only” interpretation, but the item is advocacy/commentary and does not provide full methodological details in the excerpt.

This RF Safe article argues that the “strongest” RF-EMF literature supports concern about cancer-related findings, emphasizing non-monotonic dose–response patterns in the U.S. National Toxicology Program (NTP) rat study and citing additional analyses and animal studies. It reports that FDA evaluations have downplayed the human relevance of NTP results due to high exposures and inconsistencies, and counters that some effects may occur at lower exposure levels than commonly claimed. The piece also references the Ramazzini Institute rat study as supportive evidence at lower whole-body SARs and mentions a 2024 PLOS ONE paper analyzing Ramazzini tumors, but provides limited detail in the excerpt.

RF Safe argues that an FDA-authorized therapeutic radiofrequency device (TheraBionic P1) demonstrates biologically meaningful “non-thermal” RF effects, and contrasts this with consumer wireless regulation that it says is based primarily on heating (SAR) limits set in 1996. The post frames this as a regulatory and legal gap, citing the Radiation Control for Health and Safety Act and Telecommunications Act Section 704 as factors limiting local and public-health oversight. It also references several epidemiology and animal studies (e.g., Interphone, Hardell, CERENAT, IARC 2011 classification, and the U.S. NTP rodent studies) to support the claim that non-thermal effects and health risks warrant stronger scrutiny, though the article’s presentation is advocacy-oriented.

This magazine article reviews the Japan-Korea "NTP Lite" RF animal toxicity collaboration and its relationship to prior NTP (2018) and Ramazzini Institute reports of RF-associated tumors in male rats. It notes NTP Lite used a single whole-body SAR of 4 W/kg and completed a two-year exposure phase in 2022, but final reporting is delayed with histopathology and genotoxicity work ongoing. The author highlights protocol harmonization across labs while raising concerns about unexplained animal deaths and physiological differences in exposed groups, and frames the broader evidence as supportive of RF-related cancer risk in laboratory animals.

This narrative review discusses proposed non-thermal mechanisms by which chronic, low-intensity RF-EMR from ubiquitous wireless sources may affect male reproductive health. It highlights oxidative stress, mitochondrial dysfunction, impaired testosterone synthesis/steroidogenesis, and declines in sperm quality as reported outcomes. The authors argue that current SAR/thermal-based guidelines may not capture these endpoints and call for updated standards and precautionary measures.

This review summarizes studies reporting radiofrequency radiation (RFR)-associated changes in gene expression across biological systems. Reported affected genes relate to cellular stress responses, oxidative processes, apoptosis, DNA damage detection/repair, protein repair, and neural function regulation. The authors highlight reported gene expression effects at or below 0.4 W/kg SAR and argue this challenges current guideline assumptions, while noting that not all studies find significant effects.

This conference paper uses COMSOL Multiphysics simulations to evaluate thermal and SAR-based exposure limits for modeled human skin exposed to terahertz radiation (0.1–5 THz). The authors report negligible temperature increases at power densities consistent with keeping SAR below 1.6 W/kg, but note that higher power densities can yield minimal heating while producing SAR values above recognized safety thresholds. They conclude that existing sub-THz standards are not directly transferable to the full THz band and call for updated guidelines, especially for prolonged exposure.

This dosimetric study evaluated whether existing EM safety guidelines protect individuals with conductive implants by assessing implant-related local field enhancements. Across 10 kHz to 1 GHz, the authors report large increases in psSAR10mg and local electric fields near implants, particularly below 100 MHz. In human anatomical models with implants exposed to an 85 kHz wireless power transfer coil and a 450 MHz dipole, the study reports guideline exceedances and elevated psSAR10mg, while the modeled temperature rise at 450 MHz remained under 0.4 K after six minutes. The authors conclude current guidelines are insufficient for people with implants and propose regulatory changes.

This numerical study modeled RF exposure from WiFi/5G-type antennas near a 3D brain model with implanted brain pacemakers relevant to Parkinson’s disease. SAR and temperature increases were reported to remain below ICNIRP 2020 limits across modeled conditions, with maxima at a 90° antenna-to-brain angle. Despite compliance with SAR/temperature limits, the authors report modeled thermal strain and tissue displacement that could affect postoperative efficacy, leading them to recommend caution and increased distance from phones.

This animal and in vitro study examined non-thermal 900 MHz RF-EMF exposure during prenatal and postnatal development at 0.08 and 0.4 W/kg SAR. The authors report changes consistent with altered neurodevelopment, including reduced BDNF, reduced in vivo cell proliferation, and disrupted synaptic balance in rat pup brain regions. In vitro, exposed neural stem cells showed increased apoptosis and DNA double-strand breaks and shifts in cell populations toward glial lineages. The authors conclude that regulatory-level 900 MHz exposure can disrupt key neurodevelopmental processes in rodents.